GSC
ABBV icon

Grey Street Capital’s AbbVie ABBV Stock Holding History

Grey Street Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$2.71M Buy
14,866
+12,147
+447% +$2.09M 0.37% 52
2023
Q4 		$421K Sell
2,719
-360
-12% -$52.5K 0.2% 82
2023
Q3 		$459K Sell
3,079
-41
-1% -$6.02K 0.26% 66
2023
Q2 		$420K Buy
3,120
+1,023
+49% +$150K 0.22% 68
2023
Q1 		$334K Buy
+2,097
New +$321K 0.24% 84

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Grey Street Capital's ABBV Position: Q1 2024 in Review

Grey Street Capital increased its AbbVie (ABBV) stake by 447% in Q1 2024, buying an estimated $2.09M and bringing the position to 14,866 shares worth $2.71M. The position accounts for 0.37% of the portfolio, ranked #52.

Grey Street Capital first reported a position in ABBV in Q1 2023 and has held it in 5 quarters since. 3,383 funds tracked by Wall St. Rank hold ABBV as of Q1 2024.

  • Grey Street Capital held 14,866 shares of AbbVie worth $2.71M as of Q1 2024.
  • Grey Street Capital bought 12,147 AbbVie shares in Q1 2024, an estimated $2.09M.
  • AbbVie made up 0.37% of Grey Street Capital's portfolio in Q1 2024, its #52 holding.
  • Grey Street Capital first reported a position in AbbVie in Q1 2023 and has held it in 5 quarters since.
  • 3,383 funds tracked by Wall St. Rank held AbbVie as of Q1 2024.

Based on Grey Street Capital's 13F filing for Q1 2024, filed 9 Aug 2024.